Return to Course LibraryCE Information

FACULTY


 

Dushyant V. Sahani, MD

Associate Professor of Radiology
Harvard Medical School
Director of Computed Tomography
Massachusetts General Hospital

 


 

 

 

Equipment Requirements
PC: Win7/Win8, Pentium processor or faster, at least 2GB RAM, Internet Explorer version 10/11, Mozilla FireFox version 33.0.

MAC: OS version 10.8/10.9, Intel processor, at least 2GB RAM, Safari version 6.2, FireFox 33.0


 

WednesdayDecember 9, 2015

7:00 pm EASTERN 6:00 pm CENTRAL
5:00 pm MOUNTAIN 4:00 pm PACIFIC

Click here to link to tonight's webinar.

A certified one-hour live webinar for radiologists, radiologic technologists, interventional radiologists,pediatricians, and cardiologists.

Format: Live Webinar
Credit: 1.0 AMA PRA Category 1
Credit: 1.0 ARRT Category A
Tuition:  none

Course Overview
Contrast-enhanced imaging is essential for the diagnosis and management of a multitude of diseases. Significant advancements in the detection and differentiation of disease have been made in the last decade using new and evolving contrast-enhanced imaging applications and techniques.

Current Concepts in Contrast-enhanced CT will focus on currently approved agents, their properties, and indications for use; the use of both intravenous and oral agents in the adult and pediatric populations; the role of CT contrast in the interventional and cardiology suites; and the continued expansion of the role of oral CT agents.

Educational Objectives
At the conclusion of this activity, participants should be better able to:

  • List the current CT contrast agent properties and their indications for use
  • Explain the use of intravenous (IV) contrast agents in interventional radiology and cardiology
  • Describe how IV CT contrast agents can be safely administered in the pediatric population
  • Discuss the role of oral CT contrast agents

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Physicians

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. For more information go to http://www.uems.eu/uems-activities/accreditation/eaccme.

Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.

How to Enroll and Participate
This program is offered by ICPME through WebEx webinar service at no charge to the learner.

Credit cannot be granted for group viewing. To receive credit, each attendee must sign in on a separate computer.

  • Click ENROLL NOW and follow the registration instructions to register with ICPME.
  • You will receive an email from ICPME confirming your registration.
  • At the end of the registration process, click on ACCESS WEBINAR to complete the pre-course survey as well as to register on the ICPME WebEx site.
  • Detailed log-in instructions will be sent to you via e-mail the day before the webinar.

Credit

  • To receive credit, each participant must attend the entire session and complete the postcourse evaluation within 7 days after the presentation.
  • Upon verification of your participation from the Webex event report, you will receive an email from ICPME two weeks after the event with instructions to print your certificate of credit. You will not be able to print your certificate until that time.
  • Your certificate of credit will remain in your account at www.icpme.us as a permanent record of your participation.


Faculty
Dushyant V. Sahani, MD
Dr. Sahani is an Associate Professor of Radiology at Harvard Medical School and Director of Computed Tomography at Massachusetts General Hospital. He is a board-certified radiologist and fellowship-trained in abdominal imaging and intervention at MGH.

Imaging of the liver, biliary, and pancreas has been the focus of Dr. Sahani’s work. He is currently involved in investigating tumor angiogenesis and response to novel cancer treatment methods with CT, MRI, and PET.

Dr. Sahani has delivered more than 200 lectures nationally and internationally and contributed over 250 articles and reviews to the medical literature, numerous book chapters and has authored two textbooks. His work has appeared in New England Journal of Medicine, Nature Medicine, Journal of Clinical Oncology, Clinical Gastrointestinal Radiology and Hepatology, Radiology, American Journal of Radiology, Annals of Surgery, Investigative Radiology, and European Journal of Radiology.

In addition to teaching students, residents, and fellows at Harvard Medical School, he has been a visiting professor at numerous universities in the US and abroad.

Dr. Sahani is a fellow member of several professional societies and currently serves on the Board of Directors for International Society for Computed Tomography, president elect of Society of Computed Body Tomography and Magnetic Resonance, and is chairman of the Gastrointestinal Radiology Subcommittee of the Scientific Program Committee. He was also selected to be a member of the 2015 International Visiting Professor Team of the Radiological Society of North America.

Disclosure Information
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for anyone in a position to control content will be disclosed to participants prior to the start of each activity.

The faculty has reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Dushyant V. Sahani, MD, has received research grants from GE Healthcare not related to this activity.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Trace Hutchison, PharmD
Samantha Mattiucci, PharmD, CCMEP
Linda McLean, MS 
Victoria Phoenix, BS           
Jan Schultz, RN, MSN, CCMEP
Judi Smelker-Mitchek, RN, BSN                         

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 X10


Jointly provided by

               
 

This activity is supported by an independent educational grant from GE Healthcare

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.